Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  20,671 results for ""Glucagon-Like Peptide-1 Receptor agonists""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Perioperative management of patients on glucagon-like peptide-1 receptor agonists.

  • Authors : Mizubuti GB; Department of Anesthesiology and Perioperative Medicine, Queen's University, Kingston Health Sciences Centre, Kingston, Ontario, Canada.; Ho AM

Subjects: Gastric Emptying*/Gastric Emptying*/Gastric Emptying*/drug effects ; Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/adverse effects ; Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use

  • Source: Current opinion in anaesthesiology [Curr Opin Anaesthesiol] 2024 Jun 01; Vol. 37 (3), pp. 323-333. Date of Electronic Publication: 2024 Jan 30.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8813436 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression.

  • Authors : Rivera FB; Department of Medicine, Lincoln Medical Center, New York, New York, USA.; Lumbang GNO

Subjects: Blood Pressure*/Blood Pressure*/Blood Pressure*/drug effects ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jun; Vol. 26 (6), pp. 2209-2228. Date of Electronic Publication: 2024 Mar 20.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical progress note: Glucagon-like peptide-1 receptor agonists and hospitalized patients.

  • Authors : Ravee A; Division of General Internal Medicine, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA.; Burroughs-Ray D

Subjects: Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use ; Hospitalization* ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: Journal of hospital medicine [J Hosp Med] 2024 Aug; Vol. 19 (8), pp. 716-719. Date of Electronic Publication: 2024 Apr 04.Publisher: Wiley Country of Publication: United States NLM ID: 101271025 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

A comment on 'Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials'.

  • Authors : Goldenberg RM; LMC Diabetes & Endocrinology, Vaughan, Ontario, Canada.

Subjects: Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/adverse effects ; Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use ; Thyroid Neoplasms*/Thyroid Neoplasms*/Thyroid Neoplasms*/chemically induced

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jul; Vol. 26 (7), pp. 2997-2999. Date of Electronic Publication: 2024 Apr 04.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice.

  • Authors : Milder DA; Department of Anaesthesia, Westmead Hospital, Westmead, NSW, Australia.; Milder TY

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Gastric Emptying*/Gastric Emptying*/Gastric Emptying*/drug effects

  • Source: Anaesthesia [Anaesthesia] 2024 Jul; Vol. 79 (7), pp. 735-747. Date of Electronic Publication: 2024 May 13.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0370524 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study.

  • Authors : Su YC; Department of Physical Medicine and Rehabilitation, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Hsieh PC

Subjects: Carpal Tunnel Syndrome*/Carpal Tunnel Syndrome*/Carpal Tunnel Syndrome*/surgery ; Carpal Tunnel Syndrome*/Carpal Tunnel Syndrome*/Carpal Tunnel Syndrome*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Diabetes & metabolism [Diabetes Metab] 2024 Jul; Vol. 50 (4), pp. 101545. Date of Electronic Publication: 2024 May 20.Publisher: Masson Country of Publication: France NLM ID: 9607599 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1780

Record details

Read More Add to Saved list
×
Editorial & Opinion

Weighing in on glucagon-like peptide-1 receptor agonists in dermatology.

  • Authors : Heymann WR; Division of Dermatology, Cooper Medical School of Rowan University, Camden, New Jersey. Electronic address: .

Subjects: Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/adverse effects ; Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/adverse effects

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Jul; Vol. 91 (1), pp. 29-30. Date of Electronic Publication: 2024 Apr 30.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

Read More Add to Saved list
×
Academic Journal

Glucagon-like peptide-1 receptor agonists and mental health: A meta-analysis of randomized controlled trials.

  • Authors : Silverii GA; Experimental and Clinical Biomedical Sciences Department, Diabetology Unit, Florence University, Florence, Italy.; Marinelli C

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jun; Vol. 26 (6), pp. 2505-2508. Date of Electronic Publication: 2024 Mar 06.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis.

  • Authors : Abdelmalek MF; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.; Harrison SA

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jun; Vol. 26 (6), pp. 2001-2016. Date of Electronic Publication: 2024 Mar 21.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The effect of glucagon-like peptide-1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: An updated systematic review and meta-analysis.

  • Authors : Zhang Y; National Key Laboratory for Innovation and Transformation of Luobing Theory; The Key Laboratory of Cardiovascular Remodelling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/physiopathology

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jun; Vol. 26 (6), pp. 2401-2411. Date of Electronic Publication: 2024 Mar 26.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  20,671 results for ""Glucagon-Like Peptide-1 Receptor agonists""